Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer

NCT00525161 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
11
Enrollment
OTHER
Sponsor class

Stopped Slow accrual and loss of funding

Conditions

Interventions

Sponsor

Suleiman Massarweh

Collaborators